Owolabi Lukman Femi, Raafat Ahmed, Enwere Okezie Oguamanam, Mustapha Adekunle F, Adamu Bappa, AlGhamdi Mushabab
Department of Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia.
King Abdullah Hospital, Bisha, Saudi Arabia.
J Community Hosp Intern Med Perspect. 2021 May 10;11(3):322-326. doi: 10.1080/20009666.2021.1883814.
There is growing evidence in support of ischemic stroke as a manifestation of COVID-19 infection. However, hemorrhagic transformation of ischemic stroke is rare. We present two cases of hemorrhagic infarction as presenting features in COVID-19 patients who did not have traditional cardiovascular risk factors for ischemic or hemorrhagic stroke. While the hemorrhagic infarct was from a large artery in one of the patients, the other patient had a small artery related hemorrhagic infarct. We highlighted the possible underlining mechanisms from the literature and the implication of hemorrhagic infarct for routine anticoagulant therapy in patients with COVID -19 related ischemic stroke.
越来越多的证据支持缺血性中风是新冠病毒感染的一种表现。然而,缺血性中风的出血性转化很少见。我们报告了两例以出血性梗死为首发特征的新冠病毒感染患者,他们没有缺血性或出血性中风的传统心血管危险因素。其中一例患者的出血性梗死源于大动脉,另一例患者的出血性梗死与小动脉有关。我们从文献中强调了可能的潜在机制以及出血性梗死对新冠病毒相关缺血性中风患者常规抗凝治疗的影响。